Literature DB >> 9125647

No significant changes in levels of hepatitis C virus (HCV) RNA by competitive polymerase chain reaction in blood samples from patients with chronic HCV infection.

E Yoshimura1, J Hayashi, K Ueno, Y Kishihara, K Yamaji, Y Etoh, S Kashiwagi.   

Abstract

To determine if levels of hepatitis C virus (HCV) RNA change over a several-year period, we quantified the amount of HCV RNA by competitive polymerase chain reaction. The population studied included 44 residents of a rural area with chronic HCV infection, 39 had chronic hepatitis C and 37 were patients on hemodialysis. All these Japanese patients had HCV RNA of genotype II. Blood samples were collected once a year from 1992 to 1995. From 1993 to 1995 between the groups, there was no significant difference in change of HCV RNA levels of 44 residents with chronic HCV infection, with and without liver dysfunction, nor was there any change in the 31 hemodialysis patients from 1992 to 1995. The HCV RNA levels in the 25 with chronic hepatitis who did not respond to interferon-alpha during 1992-1993 returned to pretreatment levels after the cessation of interferon treatment. In two of six hemodialysis patients who were infected with HCV during this observation period, HCV RNA was eliminated within one year, and the remaining four became HCV carriers. HCV RNA levels in the latter rose rapidly after infection and were sustained at a high level throughout the study period. Thus, HCV RNA level did not change remarkably during a three-year period, a finding which supports that it does not correlate with deterioration of liver damage and aging of HCV carriers.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9125647     DOI: 10.1023/a:1018860029661

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  19 in total

1.  Improved detection of antibodies to hepatitis C virus by the second-generation assay in patients with chronic non-A, non-B liver disease.

Authors:  J Hayashi; K Nakashima; Y Kishihara; M Ohmiya; E Yoshimura; M Hirata; S Kashiwagi
Journal:  J Infect       Date:  1993-05       Impact factor: 6.072

2.  Quantitative detection of hepatitis C virus RNA with a solid-phase signal amplification method: definition of optimal conditions for specimen collection and clinical application in interferon-treated patients.

Authors:  G L Davis; J Y Lau; M S Urdea; P D Neuwald; J C Wilber; K Lindsay; R P Perrillo; J Albrecht
Journal:  Hepatology       Date:  1994-06       Impact factor: 17.425

3.  Quantification of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: increase of the virus in advanced liver disease.

Authors:  N Kato; O Yokosuka; K Hosoda; Y Ito; M Ohto; M Omata
Journal:  Hepatology       Date:  1993-07       Impact factor: 17.425

4.  Prevalence of antibody to hepatitis C virus in hemodialysis patients.

Authors:  J Hayashi; K Nakashima; W Kajiyama; A Noguchi; M Morofuji; Y Maeda; S Kashiwagi
Journal:  Am J Epidemiol       Date:  1991-09-15       Impact factor: 4.897

5.  Possible role of high-titer maternal viremia in perinatal transmission of hepatitis C virus.

Authors:  H H Lin; J H Kao; H Y Hsu; Y H Ni; S H Yeh; L H Hwang; M H Chang; S C Hwang; P J Chen; D S Chen
Journal:  J Infect Dis       Date:  1994-03       Impact factor: 5.226

6.  Transmission of hepatitis C virus by health care workers in a rural area of Japan.

Authors:  J Hayashi; Y Kishihara; K Yamaji; E Yoshimura; Y Kawakami; K Akazawa; S Kashiwagi
Journal:  Am J Gastroenterol       Date:  1995-05       Impact factor: 10.864

7.  Serum hepatitis C virus RNA levels and liver injury in volunteer blood donors.

Authors:  N Yuki; N Hayashi; T Takehara; H Hagiwara; N Hiramatsu; M Naito; Y Kawanishi; K Katayama; A Kasahara; H Fusamoto
Journal:  Am J Gastroenterol       Date:  1994-09       Impact factor: 10.864

8.  Levels of hepatitis C virus RNA and liver histology in chronic type C hepatitis.

Authors:  S C Gordon; V P Kodali; A L Silverman; C F Dmuchowski; M S Urdea; C S Chan; J C Wilber
Journal:  Am J Gastroenterol       Date:  1994-09       Impact factor: 10.864

9.  Transmission of hepatitis C virus from mothers to infants. The Vertical Transmission of Hepatitis C Virus Collaborative Study Group.

Authors:  H Ohto; S Terazawa; N Sasaki; N Sasaki; K Hino; C Ishiwata; M Kako; N Ujiie; C Endo; A Matsui
Journal:  N Engl J Med       Date:  1994-03-17       Impact factor: 91.245

10.  Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5'-noncoding region.

Authors:  H Okamoto; S Okada; Y Sugiyama; T Tanaka; Y Sugai; Y Akahane; A Machida; S Mishiro; H Yoshizawa; Y Miyakawa
Journal:  Jpn J Exp Med       Date:  1990-08
View more
  3 in total

Review 1.  Hepatitis C virus infection in the elderly. Epidemiology, prophylaxis and optimal treatment.

Authors:  J Hayashi; S Kashiwagi
Journal:  Drugs Aging       Date:  1997-10       Impact factor: 3.923

2.  Chronic hepatitis C virus infection and increases in viral load in a prospective cohort of young, HIV-uninfected injection drug users.

Authors:  Basmattee Boodram; Ronald C Hershow; Scott J Cotler; Lawrence J Ouellet
Journal:  Drug Alcohol Depend       Date:  2011-07-02       Impact factor: 4.492

3.  Differences in the factors associated with serum viral load between genotypes 1 and 2 in patients with chronic hepatitis C.

Authors:  Shunsuke Sato; Takuya Genda; Katsuharu Hirano; Hironori Tsuzura; Yoshio Kanemitsu; Yutaka Narita; Tetsu Kikuchi; Katsuyori Ijima; Takafumi Ichida
Journal:  Hepatol Int       Date:  2011-04-02       Impact factor: 6.047

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.